DNA X (SONM): Laurence Lytton discloses 120,357 shares (8.1%)

Rhea-AI Filing Summary

DNA X, Inc. ownership filing: Laurence W. Lytton reports beneficial ownership of 120,357 shares of Common Stock, representing 8.1% of the class. The percentage is calculated based on 1,488,268 shares outstanding as of April 21, 2026. The filing notes that this total excludes warrants to purchase 22,222 shares that are subject to a 4.99% beneficial ownership limitation.

Insights

Corporate Governance Analyst

Large shareholder disclosure clarifies voting and disposition powers.

Laurence W. Lytton is reported to hold 81,469 shares with sole voting and dispositive power and 38,888 shares with shared voting and dispositive power, totaling 120,357 shares. The filing ties the 8.1% figure to an explicit share count as of April 21, 2026.

Because the filing expressly excludes 22,222 warrants constrained by a 4.99% limitation, the reported percentage reflects the disclosed calculation method; subsequent changes in outstanding shares or warrant exercises could alter the stake.

Securities Compliance Specialist

Schedule 13G/A amendment documents beneficial ownership and cap rules.

The amendment format and signature indicate a passive investor disclosure under Schedule 13G/A rather than an active acquisition statement. The filing records both sole and shared voting/dispositive powers, which is standard for disclosure of a sizable holder.

Investors should note the explicit reference to the Form 10-K/A share count used for the percentage calculation; any future amendments would need to update percentages if holdings or outstanding shares change.

Key Figures

Shares beneficially owned: 120,357 shares Percent of class: 8.1% Shares outstanding: 1,488,268 shares +3 more

6 metrics

Shares beneficially owned 120,357 shares Amount beneficially owned reported by Laurence W. Lytton

Percent of class 8.1% Calculated using outstanding shares as of April 21, 2026

Shares outstanding 1,488,268 shares Shares outstanding used for percentage calculation as of April 21, 2026

Warrants excluded 22,222 warrants Warrants to purchase shares excluded from beneficial ownership total

Sole voting power 81,469 shares Sole power to vote reported

Shared voting power 38,888 shares Shared power to vote reported

Key Terms

beneficially owned, beneficial ownership limitation, Schedule 13G/A

3 terms

beneficially owned regulatory

"The shares of Common Stock beneficially owned by the reporting person excludes warrants"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

beneficial ownership limitation regulatory

"which are subject to a 4.99% beneficial ownership limitation"

A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.

Schedule 13G/A regulatory

"This amendment format indicates a Schedule 13G/A filing"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 7)

DNA X, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

83548F309

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 83548F309

1

Names of Reporting Persons

LYTTON LAURENCE W

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 81,469.00
6	Shared Voting Power 38,888.00
7	Sole Dispositive Power 81,469.00
8	Shared Dispositive Power 38,888.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

120,357.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.1 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The shares of Common Stock beneficially owned by the reporting person excludes warrants to purchase 22,222 shares of Common Stock, which are subject to a 4.99% beneficial ownership limitation. The percentage reported herein is calculated based on 1,488,268 shares of Common Stock outstanding on April 21, 2026, as reported in the Form 10-K/A filed by the issuer for the fiscal year ended December 31, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: DNA X, Inc.
(b)	Address of issuer's principal executive offices: 4445 Eastgate Mall, Suite 200, San Diego, CA 92121
Item 2.
(a)	Name of person filing: Laurence W. Lytton
(b)	Address or principal business office or, if none, residence: 467 CENTRAL PARK WEST, NEW YORK, NY 10025
(c)	Citizenship: United States
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 83548F309
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 120,357
(b)	Percent of class: 8.1%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 81,469
	(ii) Shared power to vote or to direct the vote: 38,888
	(iii) Sole power to dispose or to direct the disposition of: 81,469
	(iv) Shared power to dispose or to direct the disposition of: 38,888
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

LYTTON LAURENCE W

Signature:	/s/ Laurence W. Lytton
Name/Title:	Reporting Person
Date:	05/15/2026

FAQ

What stake does Laurence W. Lytton hold in DNA X (SONM)?

Laurence W. Lytton beneficially owns 120,357 shares, equal to 8.1% of the Common Stock class. The percentage is calculated using 1,488,268 shares outstanding as of April 21, 2026.

How many votes does Lytton control directly?

Lytton has sole voting power over 81,469 shares and shared voting power over 38,888 shares. The filing lists both sole and shared dispositive powers in the same amounts.

Are there warrants or other instruments excluded from the ownership total?

Yes. The filing excludes warrants to purchase 22,222 shares, which are subject to a 4.99% beneficial ownership limitation, and thus are not included in the reported 120,357-share total.

What share count was used to compute the 8.1% figure?

The percentage was calculated using 1,488,268 shares outstanding as reported in the issuer's Form 10-K/A for the fiscal year ended December 31, 2025, with the effective outstanding date cited as April 21, 2026.

Does this filing indicate active trading or a change in holdings?

This Schedule 13G/A amendment discloses beneficial ownership levels and voting/dispositive powers; it does not itself state any open-market purchases or sales or describe a transaction direction in the provided excerpt.